会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Transmission power reduction in interference limited nodes
    • 干扰限制节点的传输功率降低
    • US20090239569A1
    • 2009-09-24
    • US12382525
    • 2009-03-18
    • Martin DottlingMichael FarberAndreas LobingerJurgen MichelBernhard Raaf
    • Martin DottlingMichael FarberAndreas LobingerJurgen MichelBernhard Raaf
    • H04B7/005
    • H04W52/243H04W52/34
    • A method for changing a downlink transmission power level can include receiving information about interference noise. When the interference noise satisfied a predefined level, the downlink transmission power level can be changed. Typically, the transmission power level can be decreased when the interference noise is above a predefined value. The transmission power level change can be coordinated (e.g. coordination in terms of power step size, in terms of frequency portion to which the power change is applied and in terms of time when to apply the transmission power change) with transmission power level changes in other cells. Also, interferences levels may be reassessed following the first transmission power change and the power levels are changes a second time. Optionally, only a portion of the transmission bandwidth is changed or only specific DL physical channels are considered.
    • 用于改变下行链路传输功率电平的方法可以包括接收关于干扰噪声的信息。 当干扰噪声满足预定义的水平时,可以改变下行链路传输功率电平。 通常,当干扰噪声高于预定值时,可以减小发射功率电平。 可以协调发射功率电平变化(例如,在功率阶跃尺寸上的协调,关于施加功率变化的频率部分,以及应用发射功率变化的时间)与其他发射功率电平变化 细胞。 此外,干扰水平可以在第一次发射功率改变之后重新评估,并且功率电平第二次改变。 可选地,只有一部分传输带宽被改变,或仅考虑特定的DL物理信道。
    • 7. 发明申请
    • Delivery systems for functional ingredients
    • 功能成分的输送系统
    • US20070196496A1
    • 2007-08-23
    • US11584748
    • 2006-10-23
    • Michael FarberJonathan Farber
    • Michael FarberJonathan Farber
    • A61K31/718A61K9/14
    • A61K9/0056A61K31/718
    • Oral gel delivery systems are provided that comprise an ingestible matrix within which one or more functional ingredients are substantially uniformly and completely dispersed and in which degradation of the functional ingredient(s) is minimised or eliminated. The matrix of the delivery systems comprises a carbohydrate component that comprises one or more carbohydrates that exhibit good moisture binding and low gelatinisation temperature; a sugar component comprising one or more sugars, sugar syrups and/or sugar alcohols; a hydrocolloid component, and a solvent component comprising one or more polyhydric alcohols. The delivery systems can be formulated to comprise a range of functional ingredients including various drugs and nutritional supplements.
    • 提供口服凝胶递送系统,其包含可摄取的基质,其中一种或多种功能成分基本上均匀和完全分散,并且功能成分的降解被最小化或消除。 递送系统的基质包括碳水化合物组分,其包含一种或多种表现出良好的水分结合和低糊化温度的碳水化合物; 糖组分,其包含一种或多种糖,糖浆和/或糖醇; 水胶体组分和包含一种或多种多元醇的溶剂组分。 递送系统可以配制成包括一系列功能成分,包括各种药物和营养补充剂。